Traditional Chinese medicine composition for treating / alleviating chronic fatigue syndrome, preparation method and application thereof

CN122124154APending Publication Date: 2026-06-02GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Filing Date
2026-03-24
Publication Date
2026-06-02

AI Technical Summary

Technical Problem

药物治疗多以免疫调节剂、抗抑郁药、抗焦虑药和镇静剂等药物来缓解症状,目前临床应用较多的免疫治疗疗效较差同时伴有不良反应;非药物治疗以行为认知疗法和运动疗法为主,以通过改善患者心理状态从而改善生理、心理、躯体和精神功能障碍的目的,但因患者难以坚持而收效甚微

Benefits of technology

[0008]本发明认为,慢性疲劳综合征多为病毒感染后的后遗症,迁延不愈,其标在正虚邪恋,其根本在于气阴不足,根本特点为气阴两虚。本发明从病之根本“气阴两虚”出发,提供一种治疗慢性疲劳综合征的中药组合物,为自拟方。本发明以益气养阴,凉血解毒为主的治法来治疗慢性疲劳综合征。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

This invention belongs to the field of traditional Chinese medicine, specifically relating to a traditional Chinese medicine composition for treating / relieving chronic fatigue syndrome and its application. The main active ingredients of the traditional Chinese medicine composition of this invention, by weight, include: Astragalus membranaceus 20-40 parts, Rehmannia glutinosa 10-20 parts, Cornus officinalis 5-15 parts, and Platycodon grandiflorus 5-15 parts. Animal experiments have shown that the traditional Chinese medicine composition of this invention can effectively improve the symptoms of chronic fatigue syndrome, enhance exercise endurance, improve tissue damage, regulate energy metabolism, reduce oxidative stress, and inhibit inflammatory responses. Therefore, this suggests that the traditional Chinese medicine composition of this invention can effectively treat chronic fatigue syndrome.
Need to check novelty before this filing date? Find Prior Art